Invasive pneumococcal disease surveillance Australia, 1 April to 30 June 2015

Authors

  • Rachel de Kluyver Vaccine Preventable Diseases Surveillance Section, Office of Health Protection, Australian Government Department of Health, GPO Box 9484, MDP 14, Canberra, ACT 2601

DOI:

https://doi.org/10.33321/cdi.2015.39.49

Keywords:

invasive pneumococcal disease, Australia, epidemiology, IPD

Abstract

The number of notified cases of invasive pneumococcal disease (IPD) in the 2nd quarter of 2015 was more than the previous quarter but less than the number of notified cases in the 2nd quarter of 2014. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.

Downloads

Download data is not yet available.

References

Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;7(10):e1000348.

Downloads

Published

01/09/15

How to Cite

de Kluyver, Rachel. 2015. “Invasive Pneumococcal Disease Surveillance Australia, 1 April to 30 June 2015”. Communicable Diseases Intelligence 39 (September):499-502. https://doi.org/10.33321/cdi.2015.39.49.

Issue

Vol. 39 (2015)

Section

Quarterly report

Categories

License

Copyright (c) 2015 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 > >>